- Home
- TTNP vs NDRA Comparison
TTNP vs NDRA Comparison
Compare TTNP & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- NDRA
- Stock Information
- Founded
- TTNP 1991
- NDRA 2007
- Country
- TTNP United States
- NDRA United States
- Employees
- TTNP N/A
- NDRA N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TTNP Health Care
- NDRA Health Care
- Exchange
- TTNP Nasdaq
- NDRA Nasdaq
- Market Cap
- TTNP 3.4M
- NDRA 1.9M
- IPO Year
- TTNP 1996
- NDRA 2017
- Fundamental
- Price
- TTNP $3.59
- NDRA $3.86
- Analyst Decision
- TTNP
- NDRA Strong Buy
- Analyst Count
- TTNP 0
- NDRA 1
- Target Price
- TTNP N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- TTNP 58.6K
- NDRA 10.2K
- Earning Date
- TTNP 03-31-2025
- NDRA 03-27-2025
- Dividend Yield
- TTNP N/A
- NDRA N/A
- EPS Growth
- TTNP N/A
- NDRA N/A
- EPS
- TTNP N/A
- NDRA N/A
- Revenue
- TTNP N/A
- NDRA N/A
- Revenue This Year
- TTNP N/A
- NDRA N/A
- Revenue Next Year
- TTNP N/A
- NDRA N/A
- P/E Ratio
- TTNP N/A
- NDRA N/A
- Revenue Growth
- TTNP N/A
- NDRA N/A
- 52 Week Low
- TTNP $3.03
- NDRA $3.15
- 52 Week High
- TTNP $14.80
- NDRA $1,942.50
- Technical
- Relative Strength Index (RSI)
- TTNP 48.42
- NDRA 40.19
- Support Level
- TTNP $3.20
- NDRA $3.15
- Resistance Level
- TTNP $4.39
- NDRA $4.64
- Average True Range (ATR)
- TTNP 0.47
- NDRA 0.37
- MACD
- TTNP -0.05
- NDRA -0.03
- Stochastic Oscillator
- TTNP 30.23
- NDRA 36.91
Stock Price Comparison Chart: TTNP vs NDRA
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.